Epizyme, Inc.
Combination therapy for treating cancer
Last updated:
Abstract:
The present invention relates to compositions comprising inhibitors of human histone methyltransferase DOT1L and one or more therapeutic agents, particularly anticancer agents, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Status:
Grant
Type:
Utility
Filling date:
26 Aug 2016
Issue date:
7 Jan 2020